Ha Hee-Jung, Kang Min Kyoung, Kim Jeong Hwa, Choi Youn-Hee, Song Tae-Jin
Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, 260, Gonghang-daero, Gangseo-gu, Seoul, 07804, Republic of Korea.
Department of Neurology, Seoul Chuk Hospital, Seoul, Republic of Korea.
Sci Rep. 2025 Apr 12;15(1):12573. doi: 10.1038/s41598-025-97023-1.
Although the connection between decreased kidney function and hypertension is commonly acknowledged, there is insufficient research examining the relationship between renal hyperfiltration (higher-than-normal estimated glomerular filtration rate (eGFR)) and the incidence risk of hypertension. Therefore, through a nationwide longitudinal study, our research aimed to explore the relationship between the eGFR and the incidence risk of hypertension in the general population. This research used the cohort records for the National Health Insurance Service in Korea, analyzing records from 1,873,550 individuals between the ages of 20 and 79 who underwent health check-ups between 2010 and 2011. The eGFR levels, determined by applying the 2009 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, were employed to evaluate the renal function. An incidence of hypertension was confirmed when a diagnosis of (primary or secondary) hypertension (International Classification of Diseases (ICD)-10 codes I10-I11) was noted at least once per year during outpatient or inpatient care with a prescription for antihypertensive medication or at least one more surpassing 140/90 mmHg from a health examination after the index date after excluding diagnosis of secondary hypertension. The mean age of subjects was 46.03 ± 11.24 years. The 411,029 (21.9%) hypertension cases were identified over a median follow-up of 9.53 years. In the multivariable Cox regression analysis, compared with the 5th decile, the 10th eGFR deciles (≥ 115.58 mL/min/1.73 m²) (hazard ratio (HR): 0.87, 95% confidence interval (CI)(0.85-0.88), p < 0.001) demonstrated a significant association with a reduced incidence of hypertension. Moreover, an eGFR exceeding 120 mL/min/1.73 m² was linked to a lowered likelihood of hypertension (HR: 0.78, 95% CI (0.76-0.80), p < 0.001) compared to normal eGFR levels (90 ~ 120 mL/min/1.73 m²). In contrast, in the subgroup analysis of ages over 70 years old, renal hyperfiltration was not associated with a reduced incidence of hypertension. In our study, renal hyperfiltration were associated with a reduced risk of hypertension, and this association was particularly significant in those younger than 70 years old. The association between renal hyperfiltration and a lower risk of hypertension incidence was likely to vary with age.
虽然肾功能下降与高血压之间的联系已得到普遍认可,但针对肾超滤(估计肾小球滤过率(eGFR)高于正常水平)与高血压发病风险之间关系的研究尚不充分。因此,通过一项全国性纵向研究,我们旨在探索普通人群中eGFR与高血压发病风险之间的关系。本研究使用了韩国国民健康保险服务的队列记录,分析了2010年至2011年间接受健康检查的1,873,550名年龄在20岁至79岁之间个体的记录。通过应用2009年慢性肾脏病流行病学协作组(CKD-EPI)公式确定的eGFR水平,用于评估肾功能。当在门诊或住院治疗期间每年至少有一次(原发性或继发性)高血压诊断(国际疾病分类(ICD)-10编码I10-I11)且开具了抗高血压药物处方,或者在排除继发性高血压诊断后的索引日期之后的健康检查中至少有一次血压超过140/90 mmHg时,即确诊为高血压。研究对象的平均年龄为46.03±11.24岁。在中位随访9.53年期间,共确定了411,029例(21.9%)高血压病例。在多变量Cox回归分析中,与第5分位数相比,第10个eGFR分位数(≥115.58 mL/min/1.73 m²)(风险比(HR):0.87,95%置信区间(CI)(0.85 - 0.88),p < 0.001)显示与高血压发病率降低显著相关。此外,与正常eGFR水平(90至120 mL/min/1.73 m²)相比,eGFR超过120 mL/min/1.73 m²与高血压发生可能性降低相关(HR:0.78,95% CI(0.76 - 0.80),p < 0.001)。相反,在70岁以上年龄组的亚组分析中,肾超滤与高血压发病率降低无关。在我们的研究中,肾超滤与高血压风险降低相关,且这种关联在70岁以下人群中尤为显著。肾超滤与较低的高血压发病风险之间的关联可能随年龄而异。